İNCEÇAYIR, T. Et Al. 2016. Carrier-Mediated Prodrug Uptake to Improve the Oral Bioavailability of Polar Drugs: An Application to an Oseltamivir Analogue. JOURNAL OF PHARMACEUTICAL SCIENCES , vol.105, no.2 , 925-934.

İNCEÇAYIR, T., Sun, J., Tsume, Y., Xu, H., Gose, T., Nakanishi, T., ... Tamai, I.(2016). Carrier-Mediated Prodrug Uptake to Improve the Oral Bioavailability of Polar Drugs: An Application to an Oseltamivir Analogue. JOURNAL OF PHARMACEUTICAL SCIENCES , vol.105, no.2, 925-934.

İNCEÇAYIR, TUBA Et Al. "Carrier-Mediated Prodrug Uptake to Improve the Oral Bioavailability of Polar Drugs: An Application to an Oseltamivir Analogue," JOURNAL OF PHARMACEUTICAL SCIENCES , vol.105, no.2, 925-934, 2016

İNCEÇAYIR, TUBA Et Al. "Carrier-Mediated Prodrug Uptake to Improve the Oral Bioavailability of Polar Drugs: An Application to an Oseltamivir Analogue." JOURNAL OF PHARMACEUTICAL SCIENCES , vol.105, no.2, pp.925-934, 2016

İNCEÇAYIR, T. Et Al. (2016) . "Carrier-Mediated Prodrug Uptake to Improve the Oral Bioavailability of Polar Drugs: An Application to an Oseltamivir Analogue." JOURNAL OF PHARMACEUTICAL SCIENCES , vol.105, no.2, pp.925-934.

@article{article, author={TUBA İNCEÇAYIR Et Al. }, title={Carrier-Mediated Prodrug Uptake to Improve the Oral Bioavailability of Polar Drugs: An Application to an Oseltamivir Analogue}, journal={JOURNAL OF PHARMACEUTICAL SCIENCES}, year=2016, pages={925-934} }